As new compound are now provided ten compounds, namely 1-N-(2R,3R)-4-amino-3-fluoro-2-hydroxybutyryl}-kanamycin A; 1-N-(2R,3R)-4-amino-3-fluoro-2-hydroxybuty- ryl}-2',3'-dideoxykanamycin A; 1-N-(2R,3R)-4-amino-fluoro-2-hydorxybutyryl}-2',3'-dideoxy-2'-fluorokanamycin A; 1-N-(2R,3R)-4-amino-3-fluoro-2-hydroxybutyryl}-5-deoxy-5-fluorokanamycin A; 1-N-((2R,3R)-4-amino-fluoro-2-hydrox- ybutyryl}-kanamycin B; 1-N-(2R,3R)-4-amino-3-fluoro-2-hy- droxybutyryl}-3'-deoxykanamycin B; 1-N-((2R,3R)-4-amino-3-fluoro-2-hydroxybutyryl}-3',4'-dideoxykanamycin B; 1-N-(2R,3R)-4-amino-3-fluoro-2-hydroxybutyryl}-5-deoxy-5-fluorokanamycin B; 1-N-(2R,3R)-4-amino-3-fluoro-2-hydrox- ybutyryl}-5,3'-dideoxy-5-fluorokanamycin B; and 1-N(2R,3R)-4-amino-3-fluoro-2-hydroxybutyryl}-5,3',4'-tride- oxy-5-fluorokanamycin B, which are all useful as antibacterial agent in the therapeutic treatment of bacterial infections.
现在提供了十种新化合物,即 1-N-(2R,3R)-4-
氨基-3-
氟-2-羟基丁酰基}-
卡那霉素 A;1-N-(2R,3R)-4-
氨基-3-
氟-2-羟基丁酰基}-2',3'-双脱氧
卡那霉素 A; 1-N-(2R,3R)-4-
氨基-
氟-2-羟基丁酰基}-2',3'-双脱氧-2'-
氟卡那霉素 A;1-N-(2R,3R)-4-
氨基-3-
氟-2-羟基丁酰基}-5-脱氧-5-
氟卡那霉素 A; 1-N-((2R,3R)-4-
氨基-3-
氟-2-羟基丁酰基}-
卡那霉素 B; 1-N-(2R,3R)-4-
氨基-3-
氟-2-羟基丁酰基}-3'-脱氧
卡那霉素 B;1-N-(2R,3R)-4-
氨基-3-
氟-2-羟基丁酰基}-3',4'-双脱氧
卡那霉素 B; 1-N-(2R,3R)-4-
氨基-3-
氟-2-羟基丁酰基}-5-脱氧-5-
氟卡那霉素 B;1-N-(2R,3R)-4-amino-3-fluoro-2-hydrox- ybutyryl}-5,3'-dideoxy-5-fluorokanamycin B;和 1-N(2R,3R)-4-
氨基-3-
氟-2-羟基丁酰基}-5,3',4'-三脱氧-5-
氟卡那霉素 B,它们都是治疗细菌感染的有用抗菌剂。